New Experimental Treatment for Prostate Cancer Revealed at AACR

New Experimental Treatment for Prostate Cancer Revealed at AACR SDX AACR 2023 poster 05Apr 2023.pptx PRESS RELEASE • APR 14, 2023 08:00 EDT Evexomostat (SDX-7320) shows potent anti-tumor effects in pre-clinical models of prostate cancer, including castration-resistant. New research data to be presented at AACR 2023 in Orlando, FL Leave a Reply Cancel reply You must be logged in to post a comment.

The release as fetched from its publisher. syndevrx.com ↗